Equillium, Inc.
Equillium, Inc. (EQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EQ · as of Jun 8, 2026
Key Statistics
Explore Equillium, Inc. Data
eq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 91.7%
The EQ analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $6.25, representing +125.63% upside from the current price of $2.77.
Competitors & Peers
eq competitorsEQ
COEP
CUE
FBIO
IPSC
MDCXStock Performance
Full HistoryAbout Equillium, Inc.
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorde…
what is equillium, inc. · eq stock overview · equillium, inc. company profile · who is equillium, inc. ceo · eq NASDAQ · equillium, inc. headquarters · equillium, inc. business segments
About Stock Overview & Key Data
Equillium, Inc. (EQ) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 12, 2018. As of the latest trading session, EQ stock price is $2.77, with a market capitalization of $98.4M. The stock has returned +628.95% over the past 12 months and +78.71% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Equillium, Inc. stock is Buy, with an average 12-month price target of $6.25. In fiscal year 2025, Equillium, Inc. reported revenue of — and net income of -$22.4M. For detailed data — including Equillium, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Equillium, Inc. (EQ) stock price is $2.77. The stock is traded on NASDAQ under the ticker symbol EQ. The 52-week range is $0.27 – $3.45.